The human transcription factor AP-1 is a mediator of bile acid-induced liver cell apoptosis

被引:26
作者
Bernt, C [1 ]
Vennegeerts, T [1 ]
Beuers, U [1 ]
Rust, C [1 ]
机构
[1] Univ Munich, Dept Med Grosshadern 2, Munich, Germany
关键词
bile acid; cholestasis; curcumin; cytotoxicity; liver; signal transduction;
D O I
10.1016/j.bbrc.2005.12.081
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Apoptosis induced by toxic bile acids is thought to contribute to liver injury during cholestasis. The transcription factor AP-1 is involved in the induction of apoptosis depending on stimulus and cell type. It is not known whether the major human toxic bile acid, glycochenodeoxycholic acid (GCDCA), modulates AP-1 in hepatocytes. Our data show that GCDCA (75 mu M 4 h) significantly upregulates cFos and JunB as demonstrated by microarray analysis and real-time PCR in HepG2-Ntcp hepatoma cells. GCDCA (75 mu M, 4 h) also induced AP-1 activation as determined by EMSA that was most distinct after 30 min. In parallel, AP-1 transcriptional activity increased by 40% after exposure to GCDCA. Curcumin, an AP-1 inhibitor, dose-dependently reduced (1-25 mu M) or completely abolished (50 mu M) the apoptotic effect of GCDCA. Thus, GCDCA-induced upregulation of AP-1-dependent genes appears important for the cytotoxicity of this bile acid. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:800 / 806
页数:7
相关论文
共 30 条
[11]   AP-1: A double-edged sword in tumorigenesis [J].
Eferl, R ;
Wagner, EF .
NATURE REVIEWS CANCER, 2003, 3 (11) :859-868
[12]   Tauroursodeoxycholic acid mobilizes α-PKC after uptake in human HepG2 hepatoma cells [J].
Glasova, H ;
Berghaus, TM ;
Kullak-Ublick, GA ;
Paumgartner, G ;
Beuers, U .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (06) :437-442
[13]   Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids [J].
Hirano, F ;
Tanaka, H ;
Makino, Y ;
Okamoto, K ;
Hiramoto, M ;
Handa, H ;
Makino, I .
CARCINOGENESIS, 1996, 17 (03) :427-433
[14]   Cholestatic liver disease: pathophysiology and therapeutic options [J].
Hofmann, AF .
LIVER, 2002, 22 :14-19
[15]  
Huang MT, 1997, J CELL BIOCHEM, P26
[16]  
HUANG MT, 1991, CANCER RES, V51, P813
[17]   SUPPRESSION OF C-JUN AP-1 ACTIVATION BY AN INHIBITOR OF TUMOR PROMOTION IN MOUSE FIBROBLAST CELLS [J].
HUANG, TS ;
LEE, SC ;
LIN, JK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5292-5296
[18]  
Kaminska B, 2000, ACTA NEUROBIOL EXP, V60, P395, DOI 10.55782/ane-2000-1358
[19]   Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells [J].
Kuo, ML ;
Huang, TS ;
Lin, JK .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1317 (02) :95-100
[20]  
Lin ZH, 2004, J COMPUT BIOL, V11, P683